Top Regenerative Medicine Conferences to Watch in 2026

2026 is a pivotal year for regenerative medicine. The field is moving from preclinical promise to clinical reality — major trials are launching, investment is at record levels, and the conference circuit has never been more active. This guide draws on our database of 500+ longevity and life sciences events across 50+ countries to map where the field is meeting and what topics are dominating the conversation. Updated 28 August 2026 with the full autumn calendar and the first 2027 dates.

Regenerative Medicine Conferences Still Ahead in 2026

The spring and early-summer meetings are behind us, so this is the autumn calendar: every regenerative medicine, stem cell and cell-therapy conference in our database that starts between September and December 2026, in date order. Dates and venues are checked against the organisers' own pages; the free events calendar carries the full listings and is updated weekly.

• 9-11 September, Berlin: GSCN Conference 2026, the German Stem Cell Network's annual meeting and the main European academic stem cell gathering of the autumn.
• 15-19 September, Cold Spring Harbor: Epigenetics & Chromatin Conference 2026 (CSHL), relevant to anyone following partial reprogramming.
• 22-26 September, Cold Spring Harbor (hybrid): Mechanisms of Aging 2026, the 13th CSHL ageing meeting, where senescence and reprogramming data tend to appear before publication.
• 28-30 September, London (hybrid): 6th International Conference on Tissue Engineering and Regenerative Medicine (TERMC 2026).
• 2-4 October, Miami: AASCP Ninth Annual Fall Scientific Session, the American Academy of Stem Cell Physicians' clinician-facing meeting.
• 5-7 October, Phoenix: Cell & Gene Meeting on the Mesa, the Alliance for Regenerative Medicine's partnering meeting and the commercial anchor of the autumn.
• 7-11 October, Las Vegas: 41st Clinical Applications for Age Management Medicine (AMMG), a practitioner CME conference.
• 20-22 October, Kyoto: ISSCR 2026 Kyoto International Symposium: 20 Years of iPSC Discovery.
• 26-27 October, Paris: 3rd International Conference on Cell Science and Regenerative Medicine (CSRM-2026).
• 7-10 November, Dubai: Next Generation Medicine Congress 2026.
• 11-12 November, Abu Dhabi: Revive ME 2026.
• 3-4 December, Osaka: Aging 2026: Global Summit on Aging and Longevity, the last regenerative-themed meeting of the year in our calendar.

Already held in 2026

Twenty-six regenerative-themed events in our calendar started between January and August 2026. The anchors were the World Institute of Regenerative Medicine's World Congress (San Francisco, April), the World Conference on Stem Cell & Regenerative Medicine (Zurich, April), the RegMed XB annual conference (Utrecht, June), the 22nd Global Summit on Stem Cell & Regenerative Medicine (Amsterdam, June) and the ISSCR 2026 Annual Meeting (Montréal, July). Most of them have already published their 2027 dates; those appear in the calendar as soon as the organisers confirm them.

Early 2027 dates already announced

• 1-3 April 2027, Monaco: AMWC Monaco 2027, the aesthetic and anti-ageing congress with a regenerative track.
• 8-10 April 2027, Phoenix (hybrid): Mayo Clinic Healthy Longevity Medicine: Translating Geroscience into Clinical Practice.
• 3-4 June 2027, London: 4th World Congress on Healthy Aging and Gerontology (WHAG-2027).

What Counts as a Regenerative Medicine Conference?

A regenerative medicine conference is a meeting whose programme is built around repairing or replacing damaged cells, tissues and organs: stem cell biology, cell and gene therapy, tissue engineering, organoids and, increasingly, the epigenetic reprogramming work that sits between regeneration and ageing science. In practice the label covers three quite different kinds of event, and picking the wrong kind is the most common mistake we see.

Scientific society meetings

ISSCR, GSCN and the Cold Spring Harbor meetings run on peer-reviewed abstracts, poster sessions and plenaries. The audience is academic and biotech R&D, and the payoff is seeing data months before it is published. Commercial exhibition space is small or absent.

Clinical and practitioner conferences

AASCP, AMMG and the Gulf meetings (Revive ME, Next Generation Medicine) are built for physicians who run or plan to run regenerative and age-management clinics: protocols, regulatory updates, CME credits and product exhibitions. Expect fewer new mechanisms and more implementation.

Commercial and partnering meetings

The Cell & Gene Meeting on the Mesa is the clearest example: the programme is pipeline updates and investor panels, but the real business happens in scheduled one-to-one partnering slots. Go with a meeting list, not a notebook.

How they differ from longevity conferences

Longevity conferences cover the wider healthspan agenda, from geroscience and diagnostics to investment and consumer biohacking; our guide to the 2026 longevity conference circuit maps that landscape. The overlap is real and growing: Mechanisms of Aging, the ISSCR Kyoto symposium and the Meeting on the Mesa all sit on the boundary, and a clinician interested in senolytics will find relevant sessions on both circuits. If you are choosing one event, decide first whether you are there for data, for credits or for deals, then whether you need a hybrid option (TERMC London, Mechanisms of Aging and the Mayo Clinic 2027 course all offer one), and only then look at dates.

Why 2026 Is a Turning Point for Regenerative Medicine

The global longevity biotech market reached $27.15 billion in 2024 and is projected to hit $46.61 billion by 2033. Regenerative medicine — encompassing stem cell therapies, senolytics, epigenetic reprogramming, and gene editing — sits at the core of this expansion. As these therapies move into clinical practice, wearables and biometric monitoring will play a critical role in tracking treatment outcomes.

Several signals confirm the shift from laboratory to clinic:

• Epigenetic reprogramming — NewLimit raised $130M Series B; Retro Biosciences is targeting a $1 billion raise at a $5 billion valuation.
• XPRIZE Healthspan — Awarding $10M each to the top 10 finalists for one-year clinical trials starting in 2026.
• Longevity clinic investment — More than doubled to $57 billion between 2021 and 2022, with continued acceleration.
• Stem cell momentum — Stem cells rank sixth by frequency in our Q1 2026 session content analysis (45 mentions across tracked events).

Each of these developments is driving a corresponding increase in dedicated conference sessions and full events focused on regenerative medicine topics.

Where Regenerative Medicine Conferences Are Concentrated

Regenerative medicine events cluster in cities with strong biotech and academic infrastructure. Based on our tracking:

United States

The US hosts the largest share of regenerative medicine events globally. San Francisco (15 events tracked in our database), Boston (14) and San Diego (8), anchored by major research institutions and biotech clusters, are the most active research cities. Las Vegas (12) and Miami (11) host the clinically oriented meetings aimed at practitioners and affluent consumers, and Phoenix takes the Meeting on the Mesa in October.

United Kingdom and Europe

London is the busiest European city for longevity events (26 events tracked in our database), with a strong mix of academic, clinical and investor-facing gatherings. Berlin (12 events) has a growing biotech scene that produces focused regenerative medicine programming, including the GSCN Conference in September. Zurich (8), Rome (8), Amsterdam (7) and Lisbon (7) each host notable events in the space, and Paris takes the Cell Science and Regenerative Medicine conference in October.

Asia-Pacific

Tokyo (12 events) leads Asia-Pacific, and Japan has the densest autumn programme anywhere: the World Aging & Longevity Conference (Tokyo, October), the ISSCR iPSC symposium (Kyoto, October), Next Generation Longevity and the Aging 2026 summit (both Osaka, October and December). Singapore adds the International Symposium on Aging in October. Both countries combine strong regulatory frameworks with significant investment in life sciences, making them increasingly important stops on the global circuit.

Key Topics at Regenerative Medicine Events in 2026

Regenerative medicine conferences in 2026 span a broad thematic range. Based on our session content analysis, the most prominent topics include:

Stem Cells and Cell Therapies

Still the bedrock of regenerative medicine conferences, stem cell topics appear across virtually every major event in the space. Content spans basic research (pluripotency, differentiation) through to clinical applications (CAR-T adjacent approaches, exosome therapies). Pranax raised $17 million in early 2026 for exosome-based wellness, and the ISSCR Kyoto symposium in October marks 20 years since the first induced pluripotent stem cells, so expect exosomes and reprogrammed cell products to dominate the autumn stem cell programmes.

Epigenetic Reprogramming

The hottest area in longevity biotech is becoming a fixture at major conferences. Partial cellular reprogramming — resetting epigenetic age without erasing cell identity — is moving from theoretical to clinical. Conference sessions in this area have grown substantially year over year.

Senolytics and Senescence

Clearing senescent cells remains a high-priority research area, and clinical trial results from senolytic compounds are increasingly dominating conference presentations. The pivot from animal models to human trials is generating new data that conferences are racing to include in their programmes.

Peptides and Combination Therapies

Peptides are an emerging topic in our session data (36 mentions in the Q1 2026 analysis), growing alongside broader interest in multi-pathway intervention protocols. The field is shifting from single-molecule approaches to combination therapies — cocktails of interventions designed to act on multiple ageing mechanisms simultaneously.

Who Attends Regenerative Medicine Conferences

The audience at regenerative medicine events is shifting. Academic researchers remain core participants, but corporate and industry voices now dominate the speaker roster. Investors are an increasingly visible presence, particularly at events that bridge clinical science and commercial application.

Top institutional affiliations include Harvard Medical School and Stanford, both with strong regenerative medicine programmes that are well-represented across the circuit. The full speaker composition analysis is available as a bespoke brief.

Timing Your Attendance

October is the peak month for longevity and regenerative medicine conferences globally: 58 of the 2026 events in our calendar start in October, followed by May (42), June (39) and September (39). If you are planning to attend multiple events, the May-June and September-October windows offer the densest programming. The summer months (July-August) are the quietest, useful for preparation, outreach, and abstract submission for autumn events.

Deeper Intelligence

The headline landscape is free in the quarterly Longevity Events Pulse. For organisations that need structured analysis (speaker circuits, sponsor trends, emerging topics, upcoming opportunities), our bespoke briefs answer one specific question from a database of 500+ events across 50+ countries.

Related Articles

• The Complete Guide to Longevity Conferences in 2026
• What to Expect at a Longevity Summit: Formats, Speakers & Topics
• How We Track 309 Longevity Events Worldwide